We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
-11.74%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$171M
AUM Growth
+$26.4M
Cap. Flow
+$3.79M
Cap. Flow %
2.21%
Top 10 Hldgs %
46.38%
Holding
55
New
23
Increased
12
Reduced
8
Closed
12
Avg Time Held Equity + Options
1.3 quarters
Top 10 Avg Time Held Equity + Options
1.2 quarters
Top 20 Avg Time Held Equity + Options
1 quarter
Avg Time Held Equity only
1.9 quarters
Top 10 Avg Time Held Equity only
1.6 quarters
Top 20 Avg Time Held Equity only
1.8 quarters

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$7.15M
2
EW icon
Edwards Lifesciences
EW
+$5.35M
3
ZBH icon
Zimmer Biomet
ZBH
+$5.16M
4
LLY icon
Eli Lilly
LLY
+$4.99M
5
ACRS icon
Aclaris Therapeutics
ACRS
+$3.53M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$8.8M
2
PHG icon
Philips
PHG
+$7.46M
3
CAH icon
Cardinal Health
CAH
+$4.7M
4
MEDP icon
Medpace
MEDP
+$3.46M
5
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
+$2.84M

Sector Composition

Rank Sector Weight
1 Healthcare 51.13%
2 Miscellaneous 44.03%
3 Industrials 3.39%
4 Financials 1.45%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ACAD icon
1
PUT
Acadia Pharmaceuticals
ACAD
$3.17B
$16.2M 9.48%
+563,200
New +$14.9M
2016 Q4
0 quarters
QTNT
2
DELISTED
Quotient Limited Ordinary Shares
QTNT
$10.8M 6.32%
55,944
+1,302
+2% +$282K
2014 Q4
8 quarters
SNY icon
3
PUT
Sanofi
SNY
$94.3B
$8.49M 4.95%
+210,000
New +$8.27M
2016 Q4
0 quarters
CERN
4
PUT
DELISTED
Cerner Corp
CERN
$7.07M 4.12%
149,200
+89,200
+149% +$4.74M
2016 Q2
2 quarters
GSK icon
5
GSK
GSK
$92.4B
$6.96M 4.06%
+144,649
New +$7.15M
2016 Q4
0 quarters
GSK icon
6
CALL
GSK
GSK
$92.4B
$6.55M 3.82%
+136,000
New +$6.72M
2016 Q4
0 quarters
PHG icon
7
Philips
PHG
$24.3B
$6.4M 3.74%
282,945
-341,907
-55% -$7.46M
2016 Q1
3 quarters
HRC
8
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$5.98M 3.49%
106,594
+45,295
+74% +$2.57M
2016 Q2
2 quarters
TRHC
9
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$5.81M 3.39%
388,054
-121,946
-24% -$1.56M
2016 Q3
1 quarter
EW icon
10
Edwards Lifesciences
EW
$49.4B
$5.15M 3.01%
+165,000
New +$5.35M
2016 Q4
0 quarters
CAH icon
11
PUT
Cardinal Health
CAH
$55.3B
$5.04M 2.94%
+70,000
New +$5.06M
2016 Q4
0 quarters
CAH icon
12
Cardinal Health
CAH
$55.3B
$4.96M 2.89%
68,885
-65,052
-49% -$4.7M
2016 Q1
3 quarters
LLY icon
13
Eli Lilly
LLY
$1.03T
$4.93M 2.88%
+67,000
New +$4.99M
2016 Q4
0 quarters
ZBH icon
14
Zimmer Biomet
ZBH
$17.7B
$4.82M 2.81%
+48,125
New +$5.16M
2016 Q4
0 quarters
WBA icon
15
PUT
DELISTED
Walgreens Boots Alliance
WBA
$4.72M 2.75%
+57,000
New +$4.71M
2016 Q4
0 quarters
AMGN icon
16
PUT
Amgen
AMGN
$222B
$4.39M 2.56%
+30,000
New +$4.52M
2016 Q4
0 quarters
ZTS icon
17
PUT
Zoetis
ZTS
$31B
$4.28M 2.5%
+80,000
New +$4.07M
2016 Q4
0 quarters
AGN
18
PUT
DELISTED
Allergan plc
AGN
$4.2M 2.45%
+20,000
New +$4.14M
2016 Q4
0 quarters
AAAP icon
19
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$4.1M 2.39%
153,332
+77,775
+103% +$2.61M
2015 Q4
4 quarters
ACRS icon
20
Aclaris Therapeutics
ACRS
$512M
$3.76M 2.19%
+138,441
New +$3.53M
2016 Q4
0 quarters
DMK
21
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$3.31M 1.93%
15,015
+5,508
+58% +$1.1M
2014 Q4
8 quarters
NTUS
22
DELISTED
Natus Medical Inc
NTUS
$3.16M 1.84%
90,865
+34,865
+62% +$1.37M
2016 Q3
1 quarter
PHG icon
23
CALL
Philips
PHG
$24.3B
$3.06M 1.78%
+135,056
New +$2.95M
2016 Q4
0 quarters
RIGL icon
24
Rigel Pharmaceuticals
RIGL
$887M
$3.01M 1.75%
126,339
+24,267
+24% +$695K
2016 Q1
3 quarters
AMGN icon
25
CALL
Amgen
AMGN
$222B
$2.92M 1.71%
20,000
-71,300
-78% -$10.7M
2016 Q2
2 quarters
1
2 3

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Sio Capital Management held 55 positions worth $171M, up 18% from $145M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Sio Capital Management's Q4 2016 filing shows 23 new, 12 increased, 8 reduced and 12 closed positions. Its largest new stake was GSK: 144,649 shares worth $6.96M. The largest sale was Sanofi, an estimated $8.8M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 64% a quarter earlier, followed by Miscellaneous and Industrials.

  • Sio Capital Management's largest Q4 2016 buy was GSK: 144,649 shares worth $6.96M.
  • Sio Capital Management added most to Advanced Accelerator Applications S.A. in Q4 2016, an estimated $2.61M increase.
  • Sio Capital Management's biggest Q4 2016 reduction was Philips, cutting an estimated $7.46M.
  • Sio Capital Management fully exited Sanofi in Q4 2016, selling an estimated $8.8M.
  • Sio Capital Management's ten largest holdings make up 46% of its $171M portfolio in Q4 2016.
  • Sio Capital Management opened 23 new positions and closed 12 in Q4 2016.
  • Sio Capital Management's portfolio value rose 18% quarter-over-quarter to $171M.

Based on Sio Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.